Prelude Capital Management’s ContraFect Corporation CFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-434
Closed -$127K 2284
2022
Q1
$127K Hold
434
﹤0.01% 1364
2021
Q4
$91K Hold
434
﹤0.01% 1741
2021
Q3
$141K Hold
434
﹤0.01% 1448
2021
Q2
$153K Hold
434
﹤0.01% 1414
2021
Q1
$167K Buy
434
+259
+148% +$112K ﹤0.01% 1361
2020
Q4
$71K Hold
175
﹤0.01% 1191
2020
Q3
$74K Buy
175
+17
+11% +$7.71K ﹤0.01% 1010
2020
Q2
$81K Buy
+158
New +$77.6K ﹤0.01% 1016

Other funds holding CFRX

Prelude Capital Management's CFRX Position: Q2 2022 in Review

Prelude Capital Management sold out of ContraFect Corporation (CFRX) in Q2 2022, closing a stake of 434 shares — an estimated $127K sold.

Prelude Capital Management first reported a position in CFRX in Q2 2020 and held it in 8 quarters. The position peaked at $167K in Q1 2021. 53 funds tracked by Wall St. Rank hold CFRX as of Q2 2022.

  • Prelude Capital Management reported no remaining ContraFect Corporation position as of Q2 2022 after selling out during the quarter.
  • Prelude Capital Management sold 434 ContraFect Corporation shares in Q2 2022, an estimated $127K.
  • Prelude Capital Management first reported a position in ContraFect Corporation in Q2 2020 and held it in 8 quarters.
  • Prelude Capital Management's ContraFect Corporation position peaked at $167K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held ContraFect Corporation as of Q2 2022.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.